Chronic Myeloproliferative Disorders
Showing 51 - 75 of 123
Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Detroit (Aprepitant, Cyclophosphamide, Dexamethasone)
Completed
- Breast Cancer
- +11 more
- Aprepitant
- +3 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Feb 12, 2016
Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (Dacogen)
Terminated
- Chronic Myeloproliferative Disorders
- Secondary Myelofibrosis
-
Rochester, MinnesotaMayo Clinic
Nov 25, 2015
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Atlanta, Baltimore, Philadelphia (drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- cyclophosphamide
- +5 more
-
Atlanta, Georgia
- +2 more
Sep 2, 2015
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Duarte (behavioral, dietary supplement, other, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- exercise intervention
- +11 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Jun 3, 2015
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Duarte (cytology specimen collection procedure,
Terminated
- Brain and Central Nervous System Tumors
- +9 more
- cytology specimen collection procedure
- +2 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Jun 3, 2015
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Duarte (drug, procedure, radiation)
Terminated
- Chronic Myeloproliferative Disorders
- +5 more
- fludarabine phosphate
- +6 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Jun 3, 2015
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial (drug, genetic, other, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- ganciclovir
- +7 more
- (no location specified)
Jun 3, 2015
Perceptions of Burden in Late-Stage Cancer and Their Caregivers
Withdrawn
- Brain and Central Nervous System Tumors
- +9 more
- medical chart review
- +2 more
- (no location specified)
May 27, 2015
Donor-Derived DNA in Semen Samples From Cancer Survivors Who
Terminated
- Cancer Survivor
- +8 more
- DNA analysis
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 8, 2014
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- ruxolitinib phosphate
- +2 more
-
Birmingham, Alabama
- +23 more
Oct 22, 2014
Chronic Myeloproliferative Disorders, Leukemia Trial in Jacksonville, Rochester, Houston (PS-341)
Completed
- Chronic Myeloproliferative Disorders
- Leukemia
-
Jacksonville, Florida
- +2 more
Oct 15, 2014
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Indianapolis (cilengitide)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
-
Indianapolis, IndianaIndiana University Cancer Center
Sep 16, 2014
Chronic Myeloproliferative Disorders, GVHD, Infection Trial in Phoenix, Duarte (biological, drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +10 more
- anti-thymocyte globulin
- +12 more
-
Phoenix, Arizona
- +1 more
Sep 3, 2014
Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Indianapolis (recombinant interleukin-12)
Completed
- Breast Cancer
- +10 more
- recombinant interleukin-12
-
Indianapolis, IndianaIndiana University Cancer Center
Sep 9, 2014
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Worldwide (filgrastim, allogeneic bone marrow transplantation,
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- filgrastim
- +2 more
-
Seattle, Washington
- +15 more
Mar 4, 2014
Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia Trial in San Francisco, Winston-Salem (biological, drug,
Unknown status
- Chronic Myeloproliferative Disorders
- +6 more
- anti-thymocyte globulin
- +12 more
-
San Francisco, California
- +1 more
Jan 3, 2014
Chronic Myeloproliferative Disorders, Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Cleveland (sargramostim, amifostine
Unknown status
- Chronic Myeloproliferative Disorders
- +7 more
- sargramostim
- +3 more
-
Cleveland, OhioCleveland Clinic Cancer Center
Dec 18, 2013
Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia Trial in Milwaukee (management of therapy complications, pain
Unknown status
- Chronic Myeloproliferative Disorders
- +11 more
- management of therapy complications
- pain therapy
-
Milwaukee, WisconsinMedical College of Wisconsin Cancer Center
Sep 19, 2013
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Philadelphia (biological, dietary supplement, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +3 more
- filgrastim
- +9 more
-
Philadelphia, Pennsylvania
- +1 more
Jun 25, 2013
Anxiety Disorder, Chronic Myeloproliferative Disorders, Depression Trial in New York (pain therapy, psychosocial assessment and
Completed
- Anxiety Disorder
- +6 more
- pain therapy
- psychosocial assessment and care
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 17, 2013
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New York (pyroxamide)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 4, 2013
Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases Trial run by the NHLBI
Terminated
- Chronic Myeloproliferative Disorders
- +2 more
- cyclophosphamide
- +15 more
-
Bethesda, MarylandNIH - Warren Grant Magnuson Clinical Center
Apr 30, 2013
Studying Fentanyl in Patients With Cancer
Terminated
- Brain and Central Nervous System Tumors
- +10 more
- fentanyl citrate
- pharmacological study
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 16, 2013
Chronic Myeloproliferative Disorders, Infection, Leukemia Trial in United States (amphotericin B deoxycholate, nystatin)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- amphotericin B deoxycholate
- nystatin
-
Phoenix, Arizona
- +58 more
Mar 25, 2013
Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Zion (aldesleukin, recombinant interferon alfa, sargramostim)
Completed
- Breast Cancer
- +11 more
- aldesleukin
- +2 more
-
Zion, IllinoisMidwestern Regional Medical Center
Mar 25, 2013